Comparison between Austral Coke IPO and Chemcel Bio-tech IPO.
Austral Coke IPO is a Mainboard Fixed Price IPO proposed to list at BSE, NSE while Chemcel Bio-tech IPO is a Mainboard Fixed Price proposed to list at BSE.
The total issue size of Austral Coke IPO is up to ₹142.30 Cr whereas the issue size of the Chemcel Bio-tech IPO is up to ₹22.08 Cr. The final issue price of Austral Coke IPO is ₹196.00 per share and of Chemcel Bio-tech IPO is ₹16.00 per share.
| Austral Coke IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹164.00 per share | |
| Issue Price (Upper) | ₹196.00 per share | |
| Issue Price (Final) | ₹196.00 per share | ₹16.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 34 shares | |
| Fresh Issue Size | 72,60,000 shares | 1,38,00,206 shares |
| Fresh Issue Size (Amount) | up to ₹142.30 Cr | up to ₹22.08 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 72,60,000 shares | 1,38,00,206 shares |
| Issue Size Total (Amount) | up to ₹142.30 Cr | up to ₹22.08 Cr |
Austral Coke IPO opens on Aug 07, 2008, while Chemcel Bio-tech IPO opens on Sep 09, 2008. The closing date of Austral Coke IPO and Chemcel Bio-tech IPO is Aug 13, 2008, and Sep 12, 2008, respectively.
| Austral Coke IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 07, 2008 | Sep 09, 2008 |
| Issue Close | Aug 13, 2008 | Sep 12, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 04, 2008 | Oct 13, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Austral Coke IPO P/E ratio is , as compared to Chemcel Bio-tech IPO P/E ratio of .
| Austral Coke IPO | Chemcel Bio-tech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 87.41 | 57.23 | ||||
| Promoter Shareholding (Post-Issue) | 65.56 | 29.4 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹568.98 Cr. | ₹41.47 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 10.85 | 9.14 |
In the Austral Coke IPO Retail Individual Investors (RII) are offered 25,41,000 shares while in Chemcel Bio-tech IPO retail investors are offered 25,41,000 shares. Qualified Institutional Buyers (QIB) are offered 36,30,000 shares in Austral Coke IPO and in Chemcel Bio-tech IPO.
| Austral Coke IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 36,30,000 shares | |
| NII | 10,89,000 shares | 64,00,000 shares |
| RII | 25,41,000 shares | 64,00,000 shares |
| Employee | 10,00,000 shares | |
| Others | ||
| Total | 72,60,000 shares | 1,38,00,000 shares |
Austral Coke IPO subscribed 1.65x in total, whereas Chemcel Bio-tech IPO subscribed 1.70x.
| Austral Coke IPO | Chemcel Bio-tech IPO | |
|---|---|---|
| QIB (times) | 0.62x | |
| NII (times) | 7.32x | 1.06x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.69x | 2.59x |
| Employee (times) | 0.03x | |
| Other (times) | ||
| Total (times) | 1.65x | 1.70x |
